Localized Interleukin-12 for Cancer Immunotherapy.

Nguyen, Khue G; Vrabel, Maura R; Mantooth, Siena M; Hopkins, Jared J; Wagner, Ethan S; Gabaldon, Taylor A; Zaharoff, David A

Nguyen, Khue G; Vrabel, Maura R; Mantooth, Siena M; Hopkins, Jared J; Wagner, Ethan S; Gabaldon, Taylor A; Zaharoff, David A.

Afiliação

Nguyen KG; Joint Department of Biomedical Engineering, University of North Carolina, Chapel Hill and North Carolina State University, Raleigh, NC, United States.
Vrabel MR; Joint Department of Biomedical Engineering, University of North Carolina, Chapel Hill and North Carolina State University, Raleigh, NC, United States.
Mantooth SM; Joint Department of Biomedical Engineering, University of North Carolina, Chapel Hill and North Carolina State University, Raleigh, NC, United States.
Hopkins JJ; Joint Department of Biomedical Engineering, University of North Carolina, Chapel Hill and North Carolina State University, Raleigh, NC, United States.
Wagner ES; Joint Department of Biomedical Engineering, University of North Carolina, Chapel Hill and North Carolina State University, Raleigh, NC, United States.
Gabaldon TA; Joint Department of Biomedical Engineering, University of North Carolina, Chapel Hill and North Carolina State University, Raleigh, NC, United States.
Zaharoff DA; Joint Department of Biomedical Engineering, University of North Carolina, Chapel Hill and North Carolina State University, Raleigh, NC, United States.

Front Immunol ; 11: 575597, 2020.

Article em En | MEDLINE | ID: mdl-33178203

Assuntos

Antineoplásicos/administração & dosagem; Terapia Genética; Imunoterapia; Interleucina-12/administração & dosagem; Neoplasias/terapia; Animais; Antineoplásicos/efeitos adversos; Portadores de Fármacos; Composição de Medicamentos; Técnicas de Transferência de Genes; Terapia Genética/efeitos adversos; Vetores Genéticos; Humanos; Imunoterapia/efeitos adversos; Interleucina-12/efeitos adversos; Interleucina-12/genética; Neoplasias/genética; Neoplasias/imunologia; Neoplasias/metabolismo; Resultado do Tratamento; Microambiente Tumoral

Palavras-chave

cancer immunotherapy; cancer vaccine; cytokine delivery system; interleukin-12 (IL-12); intratumoral administration; localized delivery

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Interleucina-12 / Imunoterapia / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Front Immunol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google